Neuropathic pain is a complex condition which encompasses both benign (e.g. trigeminal / post – herpetic neuralgia) and malignant etiologies. The effective management of both types of neuropathic pain often requires a multimodal approach to be relieved. Continue reading
Recent advances in techniques such as iontophoresis represent a promising approach to pain management. Iontophoresis involves the use of low-voltage electrical currents to improve transdermal delivery of medications, including local anesthetics. Continue reading
Patient’s rights mandate that every patient in chronic pain has the right to receive proper and effective treatment. It is widely acceptable that opioids can significantly improve the patient’s quality of life, irrespectable of the etiology of pain, either cancer or non-cancer.
Continue readingOpioid analgesics are widely accepted as first-line treatment for moderate to severe cancer pain: while their use in patients with non-cancer pain syndromes has increased substantially over the last years. However, opioid analgesia produces numerous adverse effects. These effects have a negative impact on patient’s quality of life, may impair adherence to treatment and finally limitate opioid use.
Continue readingOpioid use for cancer pain is well established in medical literature. Recommended by the european guidelines (European Society for Medical Oncology - ESMO, European Association for Palliative Care – EAPC), the World Health Organization (WHO) analgesic ladder remains the gold standard in cancer pain management.
Continue reading
